RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA

Clinical trials for RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immune cell therapy tested for tough blood cancers

Disease control Recruiting now

This is an early-phase study testing a new type of personalized immune cell therapy called CT0596 CAR-T. It aims to see if this treatment is safe and effective for adults with multiple myeloma or plasma cell leukemia that has come back or stopped responding to other treatments. T…

Matched conditions: RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA

Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA

Get alerted when new RELAPSED/REFRACTORY PLASMA CELL LEUKEMIA trials appear

New immune cell therapy tested for tough blood cancers